0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector
adalimumab-aacf
RxCUI: 2640859
What the CMS Formulary Data Shows for 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector
Per the CMS 2026 Part D formulary file, 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector (RxNorm concept RXCUI 2640859, generic name adalimumab-aacf) appears on 3 distinct formulary files spanning 16 Medicare Part D plan offerings - 0.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.7.
Real-world access to 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector depends on utilization management as much as tier placement: 66.7% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector today.
Coverage Details
- Formularies covering
- 3
- Plans covering
- 16
- Coverage rate
- 0.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 66.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector
16 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Community Care's Partnership Program (HMO D-SNP) | COMMUNITY CARE HEALTH PLAN, INC. | T1 | No | $0 | WI |
| Personal Choice 65 Achieve Rx (PPO) | QCC INSURANCE COMPANY | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $0 | PA |
| Keystone 65 Basic Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $0 | PA |
| AmeriHealth Medicare Core (PPO) | AMERIHEALTH INSURANCE COMPANY OF NEW JERSEY | T5 | Yes | $0 | NJ |
| AmeriHealth Medicare Ultimate (PPO) | AMERIHEALTH INSURANCE COMPANY OF NEW JERSEY | T5 | Yes | $0 | NJ |
| Keystone 65 Essential Rx (HMO-POS) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $31.00 | PA |
| AmeriHealth Medicare Enhanced (PPO) | AMERIHEALTH INSURANCE COMPANY OF NEW JERSEY | T5 | Yes | $36.00 | NJ |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $47.00 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $59.70 | PA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $63.50 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T5 | Yes | $79.70 | PA |
| Personal Choice 65 Plus Rx (PPO) | QCC INSURANCE COMPANY | T5 | Yes | $81.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T5 | Yes | $102.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T5 | Yes | $112.70 | PA |
Frequently Asked Questions
Is 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector covered by Medicare Part D?
Yes, 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector is covered by 16 Medicare Part D plans (0.3% of all Part D formularies).
What tier is 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector on Medicare Part D plans?
0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector averages Tier 3.7 across Part D plans, ranging from Tier 1 to Tier 5.
Does 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector require prior authorization?
66.7% of Part D formularies require prior authorization for 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector. Step therapy: 0%. Quantity limits: 0%.
Read our methodology - how this data is sourced, computed, and verified.